LEAP District grows to $13 billion investment
Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing under one roof.
Eli Lilly to invest $4.5bn for drug manufacturing and trial medicine production
The initiative is expected to optimise processes, boost trial medicine capacity, and reduce both costs and environmental impact.
Eli Lilly announces additional $4.5 billion investment into central Indiana LEAP District
Eli Lilly announced Wednesday it will invest another $4.5 billion into a new facility at the states controversial LEAP District in central Indiana.
Lilly announces additional $4.5 billion expansion to LEAP District
Governor Eric J. Holcomb and Eli Lilly Chair and CEO David A. Ricks announce Lilly’s plans to increase its investment at the LEAP Research and Innovation
Gov. Holcomb joins Lilly to announce additional $4.5 billion investment at LEAP District
Today, Governor Eric J. Holcomb joined Eli Lilly and Company (NYSE: LLY) Chair and CEO David A. Ricks to announce Lilly’s plans to
Eli Lilly and Company invests additional $4.5 billion to LEAP
Eli Lilly and Company announced an increased budget for the LEAP by $4.5 billion. The increased budget goes toward the Lilly Medicine Foundry in the proposed LEAP district.
LEAP District grows to $13 billion investment as Eli Lilly plans another facility
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing under one roof.
Eli Lilly and Company announce $4.5 billion investment in Lebanon LEAP district facility
On Wednesday, Eli Lilly and Company announced a $4.5 billion investment into a new "first of its kind" facility in Lebanon's LEAP district.
Lilly adds to LEAP district investments with $4.5B advanced manufacturing site
Daily Journal7h
Lilly to invest another $4.5B in Lebanon site for new ‘medicine foundry’
The new funding will bring the Indianapolis-based drugmaker’s total investment in the Lebanon site to more than $13 billion, ...
FiercePharma4h
Eli Lilly's shortage of diabetes and obesity drugs is over, halting competition with knock-offs
Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...
Business Facilities1h
Eli Lilly To Invest $4.5B To Build Medicine Foundry In Indiana
Sited in the Lebanon, IN, the pharma giant will research new ways to produce medicines and to scale up production.
The Magazine3h
Lilly announces new $4.5-billion advanced research and manufacturing site
Eli Lilly and Co. (Indianapolis, Ind.) announced a $4.5-billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing ...
FiercePharma1d
High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project
As Eli Lilly has surged to become the most valuable company in biopharma—with a market cap now more than twice that of ...
Lilly announces new $4.5 billion site - the Lilly Medicine Foundry - to drive innovation in drug production and make medicines for clinical trials
Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new ...
WISH-TV on MSN23h
Lilly officials say new facility could mean faster development, lower prices
Lilly officials on Wednesday said a newly-announced facility near Lebanon could shorten the drug research and development ...